ImageneBio (IMA) Total Current Liabilities (2020 - 2024)

Historic Total Current Liabilities for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $9.2 million.

  • ImageneBio's Total Current Liabilities fell 5205.23% to $9.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.2 million, marking a year-over-year decrease of 5205.23%. This contributed to the annual value of $14.2 million for FY2023, which is 3393.95% down from last year.
  • ImageneBio's Total Current Liabilities amounted to $9.2 million in Q3 2024, which was down 5205.23% from $8.2 million recorded in Q2 2024.
  • In the past 5 years, ImageneBio's Total Current Liabilities ranged from a high of $30.6 million in Q3 2021 and a low of $8.2 million during Q2 2024
  • For the 5-year period, ImageneBio's Total Current Liabilities averaged around $20.9 million, with its median value being $23.3 million (2022).
  • Per our database at Business Quant, ImageneBio's Total Current Liabilities plummeted by 403.43% in 2021 and then crashed by 5788.74% in 2023.
  • Quarter analysis of 5 years shows ImageneBio's Total Current Liabilities stood at $28.3 million in 2020, then decreased by 4.03% to $27.2 million in 2021, then dropped by 20.91% to $21.5 million in 2022, then crashed by 33.94% to $14.2 million in 2023, then crashed by 34.95% to $9.2 million in 2024.
  • Its last three reported values are $9.2 million in Q3 2024, $8.2 million for Q2 2024, and $10.2 million during Q1 2024.